Clinical efficacy and safety of HX575, a biosimilar recombinant human erythropoietin, in the management of anemia

Overview of attention for article published in Biosimilars, September 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Biosimilars and Interchangeable Biologics, Strategic Elements

Monograph (October 2018)

Comprehensive glycan analysis of twelve recombinant human erythropoietin preparations from manufacturers in China and Japan

Article in Journal of Pharmaceutical and Biomedical Analysis (February 2018)

Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study

Article in Clinical Nephrology (November 2017)